FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
SYNTA PHARMACEUTICALS CORP [ SNTA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 01/23/2013 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock(1) | 01/23/2013 | M | 75,000 | A | $10.843 | 277,005 | D | |||
Common Stock | 01/23/2013 | M | 5,500 | A | $7.03 | 282,505 | D | |||
Common Stock | 01/23/2013 | M | 2,500 | A | $7.03 | 285,005 | D | |||
Common Stock | 01/23/2013 | M | 5,500 | A | $2.38 | 290,505 | D | |||
Common Stock | 01/23/2013 | M | 2,500 | A | $2.38 | 293,005 | D | |||
Common Stock | 01/23/2013 | M | 5,500 | A | $2.59 | 298,505 | D | |||
Common Stock | 01/23/2013 | M | 2,500 | A | $2.59 | 301,005 | D | |||
Common Stock | 01/23/2013 | M | 5,500 | A | $5.09 | 306,505 | D | |||
Common Stock | 01/23/2013 | M | 2,500 | A | $5.09 | 309,005 | D | |||
Common Stock | 01/23/2013 | M | 5,000 | A | $5.47 | 314,005 | D | |||
Common Stock | 01/23/2013 | M | 2,250 | A | $5.47 | 316,255 | D | |||
Common Stock | 2,673,383 | I | By Wyandanch Partners, L.P.(2) | |||||||
Common Stock | 175,000 | I | By Keith R. Gollust Roth IRA |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Director Stock Option (Right to Buy) | $10.843 | 01/23/2013 | M | 75,000 | (3) | 05/27/2014 | Common stock | 75,000 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $7.03 | 01/23/2013 | M | 5,500 | (3) | 06/11/2018 | Common Stock | 5,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $7.03 | 01/23/2013 | M | 2,500 | (3) | 06/11/2018 | Common Stock | 2,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $2.38 | 01/23/2013 | M | 5,500 | (3) | 07/01/2019 | Common Stock | 5,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $2.38 | 01/23/2013 | M | 2,500 | (3) | 07/01/2019 | Common Stock | 2,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $2.59 | 01/23/2013 | M | 5,500 | (3) | 07/01/2020 | Common Stock | 5,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $2.59 | 01/23/2013 | M | 2,500 | (3) | 07/01/2020 | Common Stock | 2,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $5.09 | 01/23/2013 | M | 5,500 | (3) | 07/01/2021 | Common Stock | 5,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $5.09 | 01/23/2013 | M | 2,500 | (3) | 07/01/2021 | Common Stock | 2,500 | $0 | 0 | D | ||||
Director Stock Option (Right to Buy) | $5.47 | 01/23/2013 | M | 5,000 | (4) | 07/01/2022 | Common Stock | 5,000 | $0 | 5,000 | D | ||||
Director Stock Option (Right to Buy) | $5.47 | 01/23/2013 | M | 2,250 | (5) | 07/01/2022 | Common Stock | 2,250 | $0 | 2,250 | D |
Explanation of Responses: |
1. This Form 4 is being filed by the Reporting Person solely to report the exercise of stock options. The Reporting Person has not sold any of the shares of common stock resulting from the exercise of such stock options. |
2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
3. All shares underlying this option have vested. |
4. The option vested as to 2,500 shares on each of September 30, 2012 and December 31, 2012 and will vest as to 2,500 shares on each of March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as a director of the Issuer on such date. |
5. The option vested as to 1,125 shares on each of September 30, 2012 and December 31, 2012 and will vest as to 1,125 shares on each of March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as Chairman of the Board of Directors of the Issuer on such date. |
/s/ Brian Keane, Attorney-in-Fact | 01/24/2013 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |